Barclays PLC Has $8.80 Million Stock Holdings in Masimo Co. (NASDAQ:MASI)

Barclays PLC raised its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 33.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 53,219 shares of the medical equipment provider's stock after buying an additional 13,262 shares during the period. Barclays PLC owned about 0.10% of Masimo worth $8,796,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. FMR LLC raised its stake in Masimo by 19.8% in the 4th quarter. FMR LLC now owns 8,097,454 shares of the medical equipment provider's stock valued at $1,338,509,000 after acquiring an additional 1,340,836 shares during the period. Vanguard Group Inc. lifted its stake in shares of Masimo by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 4,586,702 shares of the medical equipment provider's stock worth $758,182,000 after buying an additional 66,215 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Masimo by 119.0% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 1,735,167 shares of the medical equipment provider's stock worth $286,823,000 after buying an additional 943,001 shares during the period. Alliancebernstein L.P. grew its stake in Masimo by 1,276.9% in the 4th quarter. Alliancebernstein L.P. now owns 947,391 shares of the medical equipment provider's stock valued at $156,604,000 after buying an additional 878,587 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in Masimo by 1.0% in the 4th quarter. Geode Capital Management LLC now owns 801,125 shares of the medical equipment provider's stock valued at $132,465,000 after acquiring an additional 8,239 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MASI has been the topic of a number of recent research reports. Piper Sandler increased their target price on Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a report on Thursday, April 10th. Finally, Wells Fargo & Company upped their price target on shares of Masimo from $193.00 to $205.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $194.80.

Insider Buying and Selling at Masimo

In related news, COO Bilal Muhsin sold 30,000 shares of the firm's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $167.49, for a total value of $5,024,700.00. Following the sale, the chief operating officer now directly owns 24,172 shares of the company's stock, valued at $4,048,568.28. This trade represents a 55.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Craig B. Reynolds sold 2,053 shares of the business's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total value of $341,064.89. Following the transaction, the director now directly owns 16,581 shares of the company's stock, valued at approximately $2,754,601.53. The trade was a 11.02 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 9.70% of the company's stock.

Masimo Price Performance

Shares of NASDAQ:MASI traded up $1.11 during trading on Friday, reaching $163.74. 324,452 shares of the company traded hands, compared to its average volume of 663,646. The firm has a market capitalization of $8.85 billion, a PE ratio of 112.92 and a beta of 1.28. The company's 50 day moving average is $165.71 and its two-hundred day moving average is $165.57. Masimo Co. has a 52 week low of $101.61 and a 52 week high of $194.88. The company has a quick ratio of 1.11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.

Masimo (NASDAQ:MASI - Get Free Report) last released its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 EPS for the quarter, beating the consensus estimate of $1.42 by $0.38. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $600.70 million for the quarter, compared to analyst estimates of $593.35 million. As a group, sell-side analysts predict that Masimo Co. will post 4.1 earnings per share for the current year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.